Table 2.
T0 | T1 | pt1 vs. t0 | |
---|---|---|---|
Ca-antagonists (gabapentin, pregabalin) | 15 (34.9%) | 17 (39.5%) | ns |
Na-antagonists | 3 (7%) | 3 (7%) | ns |
Opioids | 6 (14%) | 8 (18.6%) | ns |
NSAID* | 9 (21%) | 9 (21%) | ns |
Tricyclic antidepressants | 2 (4.7%) | 3 (7%) | ns |
SSNRI† | 2 (4.7%) | 4 (9.3%) | ns |
SSRI‡ | 1 (2.3%) | 0 (0%) | ns |
Cannabinoids | 0 (0%) | 3 (7%) | ns |
No pain medication | 15 (34.9%) | 13 (30.2%) | ns |
Nonsteroidal anti-inflammatory drugs.
Serotonin–norepinephrine reuptake inhibitors.
Selective serotonin reuptake inhibitors.